Evaluation and Management of a 45-Year-Old Man with 3-Month Chronic Cough
Initial Assessment
Begin with a focused history targeting ACE inhibitor use, smoking status, and red-flag symptoms, followed immediately by chest radiograph and spirometry. 1, 2
Critical Historical Elements
- Medication review: Discontinue any ACE inhibitor immediately regardless of temporal relationship—cough typically resolves within days to 2 weeks (median 26 days) 3, 4
- Smoking history: If the patient smokes, counsel on cessation as the primary intervention; most smoking-related coughs resolve within 4 weeks 3, 1
- Red-flag symptoms requiring urgent investigation include:
- Occupational/environmental exposures to irritants or allergens 1, 4
Mandatory Baseline Investigations
- Chest radiograph to exclude malignancy, infection, structural disease, or heart failure 1, 2, 4
- Spirometry to detect obstructive airway disease 1, 5
- Cough severity quantification using validated visual analog scales or quality-of-life questionnaires 1, 2
Systematic Empiric Treatment Algorithm
The three most common causes—upper airway cough syndrome (UACS), asthma, and gastroesophageal reflux disease (GERD)—account for over 90% of chronic cough cases and should be treated sequentially. 3, 1, 2
Step 1: Treat Upper Airway Cough Syndrome (UACS) First
- UACS is the single most common cause (18.6–81.8% of cases) and should be addressed first 1, 2
- Initiate a first-generation antihistamine-decongestant combination for 1-2 weeks 2, 4
- If prominent nasal symptoms exist, add topical intranasal corticosteroids 1
- Clinical pointers include postnasal drip sensation, throat clearing, nasal discharge, or rhinorrhea 4
Step 2: Evaluate and Treat Asthma if UACS Treatment Fails
- Asthma accounts for 14.6–41.3% of chronic cough and may present with cough as the sole manifestation 1, 4
- Normal spirometry does not exclude asthma—proceed with methacholine bronchial provocation testing if spirometry is normal 1, 4
- Initiate inhaled corticosteroids with or without bronchodilators 3
- Consider a 2-week trial of oral corticosteroids (30-40 mg prednisone daily); lack of improvement suggests cough is unlikely due to eosinophilic airway inflammation 3, 1
- Response to bronchodilators may occur within 1 week, but complete resolution can take up to 8 weeks 4
Step 3: Treat GERD if Both UACS and Asthma Treatments Fail
- GERD causes 4.6–85.4% of chronic cough and frequently occurs without gastrointestinal symptoms 1, 4
- Initiate intensive acid suppression with proton pump inhibitors plus alginates for a minimum of 3 months 1, 2
- Add comprehensive dietary modifications and lifestyle changes (not just PPIs alone) 2, 4
- Be patient: response may take 2 weeks to several months, with some patients requiring 8-12 weeks 4
- Failure to consider GERD is a frequent cause of therapeutic failure 1
Step 4: Consider Nonasthmatic Eosinophilic Bronchitis (NAEB)
- NAEB accounts for 6.4–17.2% of cases and presents with normal spirometry and no airway hyperresponsiveness 1, 4
- Treat with inhaled corticosteroids 3
Critical Management Principles
- Up to 67% of patients have multiple simultaneous causes—maintain all partially effective treatments and use additive therapy 1, 2
- Schedule follow-up within 4-6 weeks to reassess response using validated cough severity measures 1, 2, 4
- Optimize therapy for each diagnosis and check compliance before abandoning a treatment approach 3
Advanced Investigation for Refractory Cases
If empiric treatments for UACS, asthma, and GERD fail after adequate trials:
- Order high-resolution CT chest to evaluate for bronchiectasis, interstitial lung disease, or occult masses 1, 4
- Consider 24-hour esophageal pH monitoring if GERD remains suspected despite empiric therapy failure 4
- Reserve bronchoscopy for suspected foreign body, endobronchial lesions, or sarcoidosis 1, 4
- Refer to a specialized cough clinic for comprehensive evaluation 1, 2
Management of Truly Refractory Chronic Cough
Only diagnose unexplained/idiopathic cough after completing systematic evaluation and adequate therapeutic trials of all common causes. 1, 4
- Consider gabapentin starting at 300 mg once daily, escalating to maximum 1,800 mg daily in divided doses 4, 5, 6
- Speech pathology/cough control therapy is a reasonable alternative 4, 5, 6
- Low-dose morphine may be considered but carries addiction risk 4, 6
Common Pitfalls to Avoid
- Never continue ACE inhibitors in any patient with troublesome chronic cough 1, 4
- Do not proceed to extensive testing before completing adequate empiric treatment trials (4-6 weeks each) 1, 2, 6
- Do not assume a single cause—sequential and additive therapy is essential given the high frequency of multiple contributing factors 1, 2
- Do not diagnose idiopathic cough prematurely before systematically addressing UACS, asthma, GERD, and NAEB 1, 4